The Editorial Board is responsible for supporting Cochrane’s Editor in Chief (EiC) and overseeing the review production process of Cochrane Reviews. Its main role is one of strategy and support to the CRG Networks and EiC. They will oversee the review production process, but not have an operational influence on the work of the Networks.
The main roles of the Editorial Board are:
- develop editorial, publishing, and content strategies with the EiC;
- support the EiC in the implementation of changes to improve consistency in the quality and timeliness of Cochrane Review preparation and publication;
- support the EiC in the development, implementation, and audit of editorial policies and practices;
- monitor the performance of the Cochrane Library;
- work closely with the EiC to develop and oversee implementation of future strategy for the Cochrane Library.
The Editorial Board includes the eight Network SEs; a methodologist; one external member (representing the end users and with relevant experience in the area of evidence synthesis and its application in global decision making); and one representative from the Cochrane community who brings specific expertise in knowledge translation.
The Editorial Board is chaired by the EiC. Members of the Editorial Board are appointed for a renewable fixed term.
Editorial Board members
Karla Soares-Weiser: Karla is responsible for ensuring that the Cochrane Library meets its strategic goals: that the quality is of high quality and relevant to the needs of stakeholders. She also has responsibility for working with Cochrane’s publishers and others to ensure that the presentation and delivery of Cochrane content is optimal – and that it is accessible to and actionable by decision makers. Finally, she shares responsibility for ensuring that product is sustainable, and that Cochrane develops its methods appropriately, and that review authors, editorial teams and the methods community are all supported in helping to deliver high quality, high impact products and services.
Toby Lasserson: Toby works closely with the Editor in Chief to deliver the objectives and targets of the Cochrane’s Editorial and Methods Department. Toby supports the Editor in Chief by leading our global review production operations and helps to implement our goal of offering high-quality, relevant, up-to-date systematic reviews and other synthesized research evidence that informs health decision-making around the world. Toby also supports the strategic and editorial development of the Cochrane Library according to user needs, and ensures the Library remains a premier international source of healthcare evidence. Toby works closely with and supports the Cochrane Review Groups.
Lisa Bero: Professor Lisa Bero is a researcher in evidence-based health care, and is internationally known for her studies on the integrity of clinical and basic research evidence that is used to influence health policy. She directs the multidisciplinary Evidence, Policy and Influence Collaborative at the Charles Perkins Centre at the University of Sydney, focusing on bias and its influence on the integrity of research. Her work spans basic science through to translation into policy. She has contributed to Cochrane as an author, editor, Centre Director, and member and Co-Chair of Cochrane’s Governing Board. She is also a longtime contributor to the work of the World Health Organization, including serving as a member of the Guideline Review Committee, and as Chair of the Essential Medicines Committee.
Isabelle Boutron: I am a professor of epidemiology at the Paris Descartes University and a researcher at the Methods Team (INSERM- Sorbonne Paris Cité Epidemiology and Statistics Research Centre). I am deputy director of the French EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Centre, deputy director of Cochrane France and co-convenor of the Bias Methods group of the Cochrane Collaboration. I am also a member of the Methods Executive of Cochrane. I have worked on the internal and external validity of non-pharmacological trials, and led the extension of the CONSORT statement on reporting treatment trials for nonpharmacologic treatments.
Robert Boyle: Robert is the Senior Editor of the Children and Families Network, and Joint Co-ordinating Editor of Cochrane Skin. He has been involved with the Cochrane Collaboration since 2006. Robert is a Reader in Paediatric Allergy at Imperial College London, and Associate Professor of Evidence-Based Dermatology at the University of Nottingham. He is also a practicing paediatric allergist in London, UK. His clinical trial and systematic review work has focussed on interventions during pregnancy or the first year of life for preventing the onset of allergic conditions. His current research grants are using individual participant data meta-analysis to better understand the effects of early skin care on risk of allergic conditions, and understanding the impact of commercial pressures on the conduct and reporting of infant formula trials.
Michael Brown: Michael Brown is founding chair of the Department of Emergency Medicine at the Michigan State University College of Human Medicine. After graduating from medical school in 1986, he completed his emergency medicine residency training at Butterworth Hospital, where he subsequently joined the residency teaching faculty. It was during this period that he developed a passion for summarizing evidence in a form useful to clinicians. This interest led to a MSc degree in Epidemiology with a focus on forms of evidence synthesis including diagnostic test meta-analysis. Over the last decade he has been engaged in guideline development related to acute care. Michael serves as Immediate Past President for the Association of Academic Chairs of Emergency Medicine.
Cindy Farquhar: Cindy Farquhar is the Postgraduate Professor of Obstetrics and Gynaecology in the Department of Obstetrics and Gynaecology at the University of Auckland. Within the Cochrane Collaboration, she is the Co-ordinating Editor of Cochrane Gynaecology and Fertility.
Paul Garner: I was part of the original team that set up the Cochrane Collaboration, and currently I am the Co-ordinating Editor of the Cochrane Infectious Diseases Group. Our reviews have helped shape global policies in malaria, tuberculosis, and neglected tropical diseases. We lead a network of over 300 people synthesizing research to inform global, regional, and national policies in tropical infections and conditions relevant to people living in low- and middle-income countries. We work with the World Health Organization and several countries in guideline development. I am Director of a DFID Development Initiative called READ-It, working with colleagues in South Africa, Zambia, India, Nepal, China, and Norway.
John Lavis: John Lavis is relied on by policymakers and stakeholders in Canada and a broad range of countries internationally to harness research evidence, citizen values and stakeholder insights to strengthen health and social systems and get the right programs, services and products to the people who need them.
Jane Noyes: Professor Jane Noyes is Professor of Health and Social Services Research and Child Health at Bangor University, UK, and specialises in complex intervention development and evaluation and development and evaluation of evidence synthesis methodology. Jane has been involved with Cochrane since its inception and is lead convenor of the Qualitative and Implementation Methods Group. She was elected to the inaugural Cochrane Scientific Committee and was founding Co-Chair and now member of the Methods Executive. Jane has published many quantitative, qualitative and mixed-method reviews using diverse methods and supported Cochrane to diversify its review products to meet stakeholder needs and expectations.
Nicole Skoetz: Nicole Skoetz has been active in Cochrane since 2002, first as a Consumer Co-ordinator and author, then as Managing Editor and since 2011 as Co-ordinating Editor of Cochrane Haematological Malignancies Review Group (CHM). She has also been actively involved in a number of committees, including the Scientific Committee, Prognosis Implementation Strategy Group, Methods Application and Review Standards, and the Co-Eds Executive. By leading Cochrane Cancer right from the beginning in 2014, Nicole has worked to bundle expertise from Cochrane Review Groups (CRGs) and Methods Groups to identify gaps in review production in the field of cancer; engage with stakeholders; collaborate with external international cancer organizations; and apply collaboratively for funding. Nicole have also been active in identifying high-priority research areas to gain funding. She authored two Cochrane exemplar protocols on prognosis - one on prognostic factors and another one on prediction models, both funded by the Federal Ministry of Education and Research (BMBF). She also secured funding from BMBF to conduct five cancer-related network meta-analyses. She also has experience as a guideline developer, including a strong interest in interactive summary of finding tables and using GRADE effectively.
Peter Tugwell: Peter Tugwell is the Senior Editor of Cochrane Musculoskeletal, Oral, Skin and Sensory Network. Peter is a Professor in the Department of Medicine and the School of Epidemiology & Public Health at the University of Ottawa, and has a rheumatology practice in the Division of Rheumatology at the Ottawa Hospital. He was Chair of the McMaster Department of Clinical Epidemiology and Biostatistics 1979-89 and Chair of the University of Ottawa Department of Medicine 1991-2001. He holds a Canada Research Chair and is Senior Scientist in the Clinical Epidemiology Program at the Ottawa Hospital Research Institute, and is a Scientist at the Bruyere Research Institute. He currently holds two Canadian Institute of Health Research grants: one that looks at stakeholder engagement in clinical guidelines, and another that examines the criteria for scientific replication of systematic reviews.
Steven Woloshin: Steven Woloshin, MD, MS is a general internist, Professor of Medicine and Community & Family Medicine and Director of the Center for Medicine and the Media at the Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth (Lebanon, NH, USA). His research addresses the excessive fear and hope created by exaggerations and selective reporting in medical journals, advertising, and the health news. He has worked to improve the communication of medical evidence to physicians, journalists, policy makers and the public so they can make wiser decisions.
Along with Lisa Schwartz he developed and ran the NIH Medicine in the Media Workshop for over a decade. He is co-author of 2 books: Know Your Chances (selected for the National Library of Medicine bookshelf) and Overdiagnosed (winner of the Prescrire Prize), his essays have appeared in the New York Times, Washington Post and Los Angeles Times and he is a founding-organizer of the international Preventing Overdiagnosis meeting sponsored by BMJ, Dartmouth, Consumers Union and Oxford and Bond University (Australia). He has frequent collaborations with the National Cancer Institute. He serves on the editorial board of JAMA Internal Medicine, is a series consultant for the British Medical Journal and a strategic advisor to the Cochrane Collaboration Sustainable Healthcare Group. With Lisa Schwartz, he won the American Medical Writer's Association John P. McGovern award for pre-eminent contribution in research and enhancing the communication of medical evidence. He is founder and director of the Lisa Schwartz Foundation for Truth in Medicine.
Dr. Woloshin graduated Boston University School of Medicine, completed internal medicine training at NYU/Bellevue Hospital, and a research fellowship at the White River Junction VA Medical Center in Vermont.